CTOs on the Move

Milestone Scientific

www.milestone.com

 
Milestone Scientific Inc. (MLSS) is a biomedical technology research and development company that patents, designs and develops innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary applications. Milestone`s computer-controlled systems are designed to make injections precise, efficient, and virtually painless. Milestone`s proprietary DPS Dynamic Pressure Sensing technology® is our technology platform that advances the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions for local anesthesia for subcutaneous drug delivery, with specific applications for cosmetic botulinum toxin injections, epidural space identification in regional anesthesia procedures ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.milestone.com
  • 425 Eagle Rock Avenue Suite 403
    Roseland, NJ USA 07068
  • Phone: 973.535.2717

Executives

Name Title Contact Details

Similar Companies

Total Resources Intl

Total Resources Intl is a Walnut, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dormer Laboratories

Dormer Laboratories, Inc. is a Etobicoke, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Helicor

Helicor, Inc. is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

A B Dental Trends

A B Dental Trends is a Lynden, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HeartBeam

HeartBeam, Inc. (NASDAQ: BEAT) is a development stage digital healthcare company with proprietary ECG telemedicine technology that will redefine the way high risk cardiovascular patients are diagnosed in an ambulatory setting at any time and any place. Its breakthrough solution employs a reusable, credit card sized, 3D vector ECG recording device and cloud-based software capable of assisting a physician in diagnosing a wide range of cardiovascular disease. HeartBeam is initially focusing on a huge unmet need of helping diagnose heart attacks in patients outside of a medical institution. No single lead ECG technology can offer this value to patients and their physicians. This underserved market is several times larger than the cardiac arrhythmia detection market based on the prevalence of patients with coronary artery disease at high risk of heart attack